Insider Shareholders with Direct Ownership of Alaunos Therapeutics, Inc. (TCRT)
This section provides a comprehensive overview of the insiders with direct ownership of Alaunos Therapeutics, Inc. (TCRT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Alaunos Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Laurence James Neil Cooper
President and CEO |
0 | 105,693 | 1,799,280 $3.81 Million | 1 |
Jan 04, 2021
Reduced 5.55%
|
| 103,008 | 0 | 1,241,870 $2.63 Million | 3 |
Jun 22, 2022
Added 3.12%
|
|
|
Kevin S. Boyle Sr.
Chief Executive Officer |
885,000 | 86,764 | 798,236 $1.69 Million | 5 |
Sep 01, 2023
Reduced 7.85%
|
| 144,167 | 0 | 745,321 $1.58 Million | 3 |
Jun 22, 2022
Added 5.09%
|
|
|
Raffaele Baffa
Chief Medical Officer |
80,645 | 0 | 280,645 $594,967 | 1 |
May 17, 2021
Added 22.32%
|
|
Eleanor De Groot
EVP, Operations |
50,825 | 41,752 | 237,106 $502,664 | 3 |
Dec 22, 2021
Reduced 7.83%
|
|
Jill Buck
EVP, GM Gene Therapy |
31,500 | 27,894 | 231,016 $489,753 | 2 |
Mar 04, 2021
Added 12.0%
|
|
James Huang
Director |
268,333 | 0 | 188,333 $399,265 | 3 |
Jun 22, 2022
Added 29.81%
|
|
Robert Hadfield
Chief Legal Officer and Sec. |
43,500 | 26,500 | 176,819 $374,856 | 2 |
Mar 04, 2021
Added 19.74%
|
| 94,167 | 0 | 160,167 $339,554 | 3 |
Jun 22, 2022
Added 19.98%
|
|
|
Heidi Hagen
Director |
113,770 | 0 | 145,889 $309,284 | 2 |
Sep 02, 2021
Added 14.01%
|
|
Kevin G Lafond
SVP, Treasurer & CAO |
0 | 18,020 | 63,965 $135,605 | 1 |
Jan 08, 2021
Reduced 21.98%
|
|
Mary Thistle
Director |
85,000 | 0 | 45,000 $95,400 | 2 |
Jun 22, 2022
Added 47.06%
|
|
Christopher Bowden
Director |
44,167 | 0 | 44,167 $93,634 | 2 |
Jun 22, 2022
Added 47.52%
|
|
J Kevin Buchi
Director |
4,167 | 0 | 4,167 $8,834 | 1 |
Mar 04, 2021
Added 50.0%
|